Log in | Register

Home
All Journals
Expert Review of Anticancer Therapy
List of Issues
Volume 19, Issue 6

Expert Review of Anticancer Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Review of Anticancer Therapy, Volume 19, Issue 6 (2019)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 19, Issue 6 (2019)

See all volumes and issues

Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Volume 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Third generation EGFR TKI landscape for metastatic EGFR mutant non-small cell lung cancer (NSCLC)

Aaron C. Tan, Yi Lin Teh, Gillianne G. Y. Lai & Daniel S. W. Tan

Pages: 431-435

Published online: 14 Apr 2019

First Page PreviewforThird generation EGFR TKI landscape for metastatic EGFR mutant non-small cell lung cancer (NSCLC) | Full Text | References | PDF (707.4 KB) | EPUB

4076 Views
9 CrossRef citations
0Altmetric

Free Access

Drug Profile

Article

Rucaparib in the landscape of PARP inhibition in ovarian cancer

Emeline Colomba, Patricia Pautier, Fanny Pommeret & Alexandra Leary

Pages: 437-446

Published online: 16 May 2019

AbstractforRucaparib in the landscape of PARP inhibition in ovarian cancer | Full Text | References | PDF (931.3 KB) | EPUB

389 Views
2 CrossRef citations
0Altmetric

Special Report

Article

Adjuvant therapeutic approaches of HER2-positive breast cancer with a focus on neratinib maleate

N. Kotecki, A. Gombos & A. Awada

Pages: 447-454

Published online: 13 May 2019

AbstractforAdjuvant therapeutic approaches of HER2-positive breast cancer with a focus on neratinib maleate | Full Text | References | PDF (634.6 KB) | EPUB

197 Views
8 CrossRef citations
0Altmetric

Perspective

Article

Starvation in cancer cells: circulating arginine is good for cancer but bad for patients

Nilesh Kumar Sharma, Sachin C Sarode, Gargi S Sarode & Shankargouda Patil

Pages: 455-459

Published online: 27 May 2019

AbstractforStarvation in cancer cells: circulating arginine is good for cancer but bad for patients | Full Text | References | PDF (706.5 KB) | EPUB

173 Views
2 CrossRef citations
0Altmetric

Review

Novel targeted strategies to overcome resistance in small-cell lung cancer: focus on PARP inhibitors and rovalpituzumab tesirine

Robin Van Den Borg, Alessandro Leonetti, Marcello Tiseo, Elisa Giovannetti & Godefridus J. Peters

Pages: 461-471

Published online: 31 May 2019

AbstractforNovel targeted strategies to overcome resistance in small-cell lung cancer: focus on PARP inhibitors and rovalpituzumab tesirine | Full Text | References | PDF (988.8 KB) | EPUB

3466 Views
9 CrossRef citations
0Altmetric

Open Access

Review

Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma

Veethika Pandey & Peter Storz

Pages: 473-482

Published online: 31 May 2019

AbstractforTargeting the tumor microenvironment in pancreatic ductal adenocarcinoma | Full Text | References | PDF (1.1 MB) | EPUB

924 Views
22 CrossRef citations
0Altmetric

Review

Prodrugs for targeted cancer therapy

Carla Souza, Diogo Silva Pellosi & Antonio Claudio Tedesco

Pages: 483-502

Published online: 13 May 2019

AbstractforProdrugs for targeted cancer therapy | Full Text | References | PDF (2.5 MB) | EPUB

1796 Views
40 CrossRef citations
0Altmetric

Review

Risk stratification of upper tract urothelial carcinoma: A Review of the Current Literature

Mehdi Kardoust Parizi, Petr V. Glybochko, Dmitry Enikeev, Morgan Rouprêt, Harun Fajkovic, Veronika Seebacher & Shahrokh F. Shariat

Pages: 503-513

Published online: 27 May 2019

AbstractforRisk stratification of upper tract urothelial carcinoma: A Review of the Current Literature | Full Text | References | PDF (846.7 KB) | EPUB

264 Views
3 CrossRef citations
0Altmetric

Review

An update on synthetic high-density lipoprotein-like nanoparticles for cancer therapy

Stephen E. Henrich & C. Shad Thaxton

Pages: 515-528

Published online: 31 May 2019

AbstractforAn update on synthetic high-density lipoprotein-like nanoparticles for cancer therapy | Full Text | References | PDF (1.2 MB) | EPUB

338 Views
11 CrossRef citations
0Altmetric

Original Research

Article

Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism?

Mehran Afshar, Hiten R. H. Patel, Ankit Jain, Abhishek Kumar, Prashant Patel, Nicholas D. James & Emilio Porfiri

Pages: 529-532

Published online: 02 May 2019

AbstractforChronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism? | Full Text | References | PDF (685.3 KB) | EPUB

120 Views
1 CrossRef citations
0Altmetric

Article

The impact of epidermal growth factor receptor mutations on the efficacy of definitive chemoradiotherapy in patients with locally advanced unresectable stage III non-small cell lung cancer: a systematic review and meta-analysis

Qin Qin, Bing Peng & Baosheng Li

Pages: 533-539

Published online: 28 May 2019

AbstractforThe impact of epidermal growth factor receptor mutations on the efficacy of definitive chemoradiotherapy in patients with locally advanced unresectable stage III non-small cell lung cancer: a systematic review and meta-analysis | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental

203 Views
5 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Risk-stratification for treatment de-intensification in WNT-pathway medulloblastoma: finding the optimal balance between survival and quality of survivorship

Tejpal Gupta et al.

Review Article | Published online: 18 May 2024

Safety and hematological toxicities of PARP inhibitors in patients with cancer: a systematic review of randomized controlled trials and a pharmacovigilance analysis

Meng-Fei Dai et al.

Review Article | Published online: 18 May 2024

Efficacy and safety of neoadjuvant therapy for HR-positive/HER2-negative early breast cancer: a Bayesian network meta-analysis

Ruiliang Chen et al.

Review Article | Published online: 17 May 2024

Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important?

Pasquale Vitale et al.

Editorial | Published online: 13 May 2024

Free Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Review of Anticancer Therapy (Vol.19, Iss.6, 2019)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?